Check-Cap (MBAI) Net Income Growth (3y) (2017 - 2024)
Check-Cap (MBAI) Net Income Growth (3y) (2017 - 2024) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 8.44% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -7.69% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 15.47% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 3.93% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -6.41% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 14.70% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 42.35% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 2.87% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 16.51% |
| 10 | Check-Cap | 5.89 Mn | -793.79 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 30.04% |
| Dec 31, 2023 | -8.26% |
| Sep 30, 2023 | 107.80% |
| Jun 30, 2023 | -76.06% |
| Mar 31, 2023 | 48.80% |
| Dec 31, 2022 | -70.89% |
| Sep 30, 2022 | 111.30% |
| Jun 30, 2022 | -12.74% |
| Mar 31, 2022 | -22.81% |
| Dec 31, 2021 | -20.84% |
| Sep 30, 2021 | 52.82% |
| Jun 30, 2021 | 51.48% |
| Mar 31, 2021 | 54.34% |
| Dec 31, 2020 | -93.81% |
| Sep 30, 2020 | 35.29% |
| Jun 30, 2020 | -33.04% |
| Mar 31, 2020 | -8.91% |
| Dec 31, 2019 | -16.82% |
| Sep 30, 2019 | 32.04% |
| Jun 30, 2019 | -34.79% |